top of page
The Professional Network for Healthcare Experts
FDA approves Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine for 2026–2027 season
The updated Comirnaty formulation targets the XFG variant and will begin shipping immediately for eligible older adults and people aged five to 64 at increased risk of severe COVID-19.
nuaxia
Aug 282 min read
European Commission authorises Pfizer-BioNTech XFG-adapted COVID-19 vaccine for the 2026–2027 vaccination season
The updated vaccine is authorised for individuals aged six months and older and aligns the EU COVID-19 vaccination programme with the currently circulating XFG variant.
nuaxia
Jul 312 min read
bottom of page